Di Battista J A, Doré S, Martel-Pelletier J, Pelletier J P
Department of Medicine, University of Montreal, Quebec, Canada.
Mol Cell Endocrinol. 1996 Oct 14;123(1):27-35. doi: 10.1016/0303-7207(96)03887-7.
Prostaglandin E2 (PGE2) stimulates collagen gene promoter activity in transfected human chondrocytes though no canonical cyclic AMP (cAMP) response element has been yet identified. Human insulin-like growth factor-1 (IGF-1) induces an increase in collagen type II expression and synthesis in chondrocytes. Since our preliminary data suggested that PGE2 can stimulate IGF-1 release from human articular chondrocytes, we examined whether the eicosanoid could influence collagen synthesis and whether the effect was mediated by IGF-1. Incubation of primary cultures of human articular chondrocytes with increasing concentrations of PGE2 resulted in a dose-dependent (ANOVA, F= 51.62, P < 0.0001, n = 5) and saturable increase in the synthesis and release of IGF-1 and expression of IGF-1 mRNA. At relatively low concentrations (30 pmol/1 to 30 nmol/l), PGE2 stimulated an increase in the incorporation of [3H]proline into collagenase digestible protein (CDP) (P < 0.01, n = 5) whereas at high levels (300 nmol/l to 3 micromol/l) of the eicosanoid, incorporation diminished precipitously. Human IGF-1 mimicked the effects of low PGE2 concentrations by stimulating in a dose-dependent (ANOVA, F= 31.65, P < 0.001, n = 3) and saturable fashion the incorporation of [3H]proline into CDP although the magnitude of the response induced by IGF-1 was far greater (3.5-fold). An IGF-1 receptor blocking antibody completely abrogated the IGF-1 induced response suggesting that the effect was specifically IGF-1 receptor mediated. Furthermore, the PGE2-induced increase in [3H]proline incorporation into CDP was inhibited (63%, P < 0.001, n = 7) by the addition to the culture medium of an anti-IGF-1 antibody. We conclude that PGE2 may act as a secretagogue of IGF-1 and that the latter growth factor may mediate, via an autocrine loop and the IGF-1 receptor, at least some of the anabolic effects of the eicosanoid on cartilage metabolism.
前列腺素E2(PGE2)可刺激转染人软骨细胞中的胶原蛋白基因启动子活性,尽管尚未鉴定出典型的环磷酸腺苷(cAMP)反应元件。人胰岛素样生长因子1(IGF-1)可诱导软骨细胞中II型胶原蛋白表达和合成增加。由于我们的初步数据表明PGE2可刺激人关节软骨细胞释放IGF-1,因此我们研究了这种类花生酸是否会影响胶原蛋白合成,以及该作用是否由IGF-1介导。用人关节软骨细胞原代培养物与浓度不断增加的PGE2孵育,导致IGF-1的合成、释放及IGF-1 mRNA表达呈剂量依赖性(方差分析,F = 51.62,P < 0.0001,n = 5)且达到饱和性增加。在相对较低浓度(30 pmol/L至30 nmol/L)时,PGE2刺激[3H]脯氨酸掺入胶原酶可消化蛋白(CDP)增加(P < 0.01,n = 5),而在类花生酸的高水平(300 nmol/L至3 μmol/L)时,掺入量急剧减少。人IGF-1通过以剂量依赖性(方差分析,F = 31.65,P < 0.001,n = 3)和饱和方式刺激[3H]脯氨酸掺入CDP,模拟了低PGE2浓度的作用,尽管IGF-1诱导的反应幅度要大得多(3.5倍)。一种IGF-1受体阻断抗体完全消除了IGF-1诱导的反应,表明该作用是由IGF-1受体特异性介导的。此外,通过向培养基中添加抗IGF-1抗体,PGE2诱导的[3H]脯氨酸掺入CDP增加受到抑制(63%,P < 0.001,n = 7)。我们得出结论,PGE2可能作为IGF-1的促分泌素,并且后者生长因子可能通过自分泌环路和IGF-1受体介导类花生酸对软骨代谢的至少一些合成代谢作用。